Suchergebnisse - "Gumucio-Sanguino, Víctor Daniel"

PubPharm (8)

1

Long-Term Effects of a Stepwise, Multimodal, Non-Restrictive Antimicrobial Stewardship Programme for Reducing Broad-Spectrum Antibiotic Use in the ICU

enthalten in: Antibiotics (Basel, Switzerland) | 2024

von Ronda, M. | Gumucio-Sanguino, V. | Shaw, E. | +11

2

Voriconazole Pharmacokinetics in Critically Ill Patients and Extracorporeal Membrane Oxygenation Support : A Retrospective Comparative Case-Control Study

enthalten in: Antibiotics (Basel, Switzerland) | 2023

von Ronda, M. | Llop-Talaveron, J. | Fuset, M. | +9

3

Predictive Factors of Piperacillin Exposure and the Impact on Target Attainment after Continuous Infusion Administration to Critically Ill Patients

enthalten in: Antibiotics (Basel, Switzerland) | 2023

von Martínez-Casanova, J. | Esteve-Pitarch, E. | Colom-Codina, H. | +10

4

Individual outcome prediction models for patients with COVID-19 based on their first day of admission to the intensive care unit

enthalten in: Clinical biochemistry | 2022

von Rigo-Bonnin, R. | Gumucio-Sanguino, V. | Pérez-Fernández, X. | +9

5

Continuous Infusion of Piperacillin/Tazobactam and Meropenem in ICU Patients Without Renal Dysfunction : Are Patients at Risk of Underexposure?

enthalten in: European journal of drug metabolism and pharmacokinetics | 2021

von Esteve-Pitarch, E. | Gumucio-Sanguino, V. | Cobo-Sacristán, S. | +9

6

Continuous Infusion of Piperacillin/Tazobactam and Meropenem in ICU Patients Without Renal Dysfunction: Are Patients at Risk of Underexposure?

enthalten in: European journal of drug metabolism and pharmacokinetics | 2021

von Esteve-Pitarch, E. | Gumucio-Sanguino, V. | Cobo-Sacristán, S. | +9

7

Continuous Infusion of Piperacillin/Tazobactam and Meropenem in ICU Patients Without Renal Dysfunction: Are Patients at Risk of Underexposure?

enthalten in: European journal of drug metabolism and pharmacokinetics | 2021

von Esteve-Pitarch, E. | Gumucio-Sanguino, V. | Cobo-Sacristán, S. | +9

8

Continuous Infusion of Piperacillin/Tazobactam and Meropenem in ICU Patients Without Renal Dysfunction: Are Patients at Risk of Underexposure?

enthalten in: European journal of drug metabolism and pharmacokinetics | 2021

von Esteve-Pitarch, E. | Gumucio-Sanguino, V. | Cobo-Sacristán, S. | +9

1
[1]